Brain-scan study in catatonia and hebephrenia with stable schizophrenia
Part of Mental health clinical trials.
This study measures brain signals during scans to look for patterns linked to two types (subforms) of psychotic disorders. If you have schizophrenia or schizoaffective disorder and your symptoms have been stable, you may be able to help researchers understand these brain markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (male or female) and agree to take part by signing the legal consent form
- If you are a patient: you have schizophrenia or schizoaffective disorder, and you meet criteria for periodic catatonia or hebephrenia
- Your condition has been clinically stable for at least 2 months
- You do not have a psychiatric history if you are a control (non-patient)
- You do not have certain health issues like unstable medical illness, substance use problems, major depression, or a history of neurological problems (like epilepsy or brain injury/surgery)
- If you are pregnant or breastfeeding, you cannot join; and if you’re taking part in scanning as a control, you must be able to safely have an fMRI scan and avoid certain psychiatric medicines for 3 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early (Phase 1) study uses a special brain scan to look at synapses—the contact points between brain cells—in people with schizophrenia-related conditions. It helps researchers understand brain activity and connection patterns, which may guide future tests or treatments.
This study uses brain scans to look at how a specific brain area works in schizophrenia. If you qualify, it may help researchers better understand the brain changes linked to symptoms.
This study builds a database of brain-signal measurements to help find “biomarkers” that may point to schizophrenia or related mental illnesses. Depending on whether you have a mental health diagnosis or you’re healthy, the study will collect information and brain data to compare groups.
This study looks at how psychiatric and neurological conditions affect thinking and memory skills. By comparing patients with healthy volunteers, researchers hope to better understand these cognitive problems and find new ways to help.
This study uses a special brain scan (functional MRI) to look at how schizophrenia affects thinking and memory. It may help researchers understand why some people with schizophrenia have trouble with concentration, planning, or remembering things.
This study uses brain scans (PET and MRI) to see how a specific receptor, called D3, is affected by antipsychotic medications in people with schizophrenia. You may be able to participate if you have not taken antipsychotics for at least 3 weeks and are not using nicotine products.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.